News Category AllNon-regulatory ReleasesRegulatory Releases Year All2024202320222021202020192018 Oct 2, 2024 Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer Sep 19, 2024 Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award Aug 29, 2024 Oculis to Present at Upcoming September Investor Conferences Aug 27, 2024 Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update Aug 15, 2024 Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer Jul 30, 2024 Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference Jun 27, 2024 Oculis and EURETINA Announces the Ramin Tadayoni Award Jun 10, 2024 Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy Jun 4, 2024 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities May 30, 2024 Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board